Tough it out.

This pooled analysis of two prospective trials including >1K patients receiving neoadjuvant chemoradiation for rectal cancer demonstrates significantly higher rates of diarrhea and leukopenia among women...but no difference in rates of treatment completion. | Diefenhardt, JAMA Oncol 2019